Atlanta Declaration, 140

AZT, 52, 59, 67, 70, 91-92, 98, 105, 106-108, 191

B

Baltimore, Almarez case, 61

STD clinics, 40

Barrier protection, in health care settings, 12, 67-68

see also Condoms

Behavioral risks

criminal endangerment, 35-37

modification of, 25, 26, 37-38

and religion, 15, 141

see also Intravenous drug use and users;

Sexual behavior

Belmont report, 87-88

Bergalis, Kimberly, 62

Black Death, see Bubonic plague

Black population, see African Americans

Blacks Educating Blacks about Sexual Health issues, 150

Bloodborne Pathogens Standard, 59

Blood donation, 161-162

Boarder babies, 206-207, 290

Braschi v. Stahl Associates Co., 230, 232-235

Breast cancer, patient activism, 99

Britt, Harry, 221-222, 227

Broder, Samuel, 91

Bronchoscopies, 71

Bubonic plague, 5, 6, 7, 125

Budgets, see Costs of care;

Financing

Burroughs-Wellcome, 67, 91, 92, 167

C

Cancer

clinical trials, 100

hospice care, 52

patient activism, 99

Cardiac Arrhythmia Suppression Trial, 104

Caregivers, see Health care workers;

Volunteers and volunteer organizations

Case definition, expansion of, 21

Case management, 11, 53-55

in Miami, 208

in New York City, 205-206

Cases, see Incidence

Catastrophic health insurance claims, 46

Catholicism, see Roman Catholicism

Centers for Disease Control (CDC), 21, 23-24, 31, 32-33, 59, 119-120

Certification of professionals, 41, 55, 68

Charitable contributions, 123, 161, 169-171

Children, 17-18, 105, 131, 203-215, 236-237, 279

in clinical trials, 18, 105, 218-219

of infected mothers, 18, 203-204, 289

in New York City, 279, 289-291

see also Foster care;

Perinatal transmission

Cholera, 5, 126

Christian Broadcasting Network, 131

Christianity, 123, 127-129

doctrinal responses to AIDS, 15, 129-149 passim

and epidemics, 5, 6, 125-127

Chronic granulomatous disease (CGD), 103-104

Churches, see Religion and religious groups

Church of Jesus Christ of Latter-Day Saints, 143-144

Citizens' Commission on AIDS, 295

Civil rights, see Rights and liberties

Clinical research, see Clinical trials;

Drugs, development of;

Experimental treatment

Clinical trials, 13, 95-97, 99-104

access to, 100, 104-108

advisory boards for, 83, 96, 97

and alternative treatments, 99

AZT, 91

and children, 18, 105, 218-219

double-blind, 82

ethical issues, 82-84, 87-88, 103, 105, 107-108, 112-113



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement